MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Development and validation of diagnostic criteria for advanced Parkinson disease: the CDEPA questionnaire

    M.-R. Luquin, J. Kulisevsky, P. Martinez-Martin, P. Mir, E. Tolosa, P. Garcia-Delgado (Pamplona, Spain)

    Objective: Using the Delphi methodology we previously obtained a consensus on the definition and clinical characteristics of advanced Parkinson’s disease (APD). We aimed to develop…
  • 2017 International Congress

    Parkinson’s disease subtypes correlate with clinical severity: a Brazilian population study

    C. Batista, M. Medeiros, C. Rieder, A. Schuh (Porto Alegre, Brazil)

    Objective: To correlate Parkinson's disease (PD) subtypes with a clinical severity in a Brazilian population sample. Background: Current studies have shown that PD may comprise…
  • 2017 International Congress

    The Adult Spasticity International Registry (ASPIRE) Study: 1 Year Results

    G. Francisco, D. Bandari, G. Bavikatte, W. Jost, A. Manack Adams, J. Largent, A. Esquenazi (Houston, TX, USA)

    Objective: To evaluate the 1-year interim onabotulinumtoxinA safety, effectiveness, and exploratory treatment utilization data from the ASPIRE study. Background: OnabotulinumtoxinA treatment for patients with spasticity…
  • 2017 International Congress

    Joint pain as premonitory urge in patient with Ehlers Danlos Syndrome and Tourette’s Syndrome

    A. Fraint, G. Pal (Chicago, IL, USA)

    Objective: We report the case of a 21 year old male with Ehlers-Danlos syndrome (EDS) and Attention Deficit Hyperactivity Disorder (ADHD) who presented with joint…
  • 2017 International Congress

    Physical Mobility Predictors and the Bone Health in Parkinson’s Disease

    L. LEANDRO, C. MOREIRA, H. TEIVE (Curitiba, Brazil)

    Objective: Evaluate the physical mobility and functionality by the ratio of bone mineral density in Parkinson’s disease. Background: Bone loss in Parkinson’s disease (PD) may…
  • 2017 International Congress

    Impact of injection interval on patient satisfaction in the routine treatment of cervical dystonia with abobotulinumtoxinA

    R. Trosch, V. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

    Objective: Evaluate the impact of injection interval on patient satisfaction with abobotulinumtoxinA (AboBoNT-A; Dysport®) over 1 injection cycle in patients with cervical dystonia (CD). Background:…
  • 2017 International Congress

    Non motor symptoms in patients with Writer’s cramp

    R. Singh, P. Chatterjee, S. Choudhury, S. Anand, S. Shubham, S. Trivedi, H. Kumar (Kolkata, India)

    Objective: We aim to explore the non-motor features of WC patients and correlate those with motor symptoms.  Background: Writer’s cramp (WC) is essentially a motor…
  • 2017 International Congress

    Combined effects of rTMS and botulinum toxin therapy in benign essential blepharospasm

    A. Wagle Shukla, J. Legacy, W. Deeb, W. Hu (Gainesville, FL, USA)

    Objective: To determine whether repetitive transcranial magnetic stimulation (rTMS) of anterior cingulate cortex (ACC) when added to botulinum toxin (BoNT) therapy improves benign essential blepharospasm…
  • 2017 International Congress

    Efficacy of miglustat in Korean patients with Niemann-Pick disease type C

    J.W. Kim, S.-Y. Lee, R. Kim (Busan, Republic of Korea)

    Objective: The first two Korean patients in siblings of adolescent/adult onset NP-C were evaluated for the efficacy of miglustat. Background: Niemann-Pick disease type C (NP-C)…
  • 2017 International Congress

    Validation of the MDS Research Criteria for Prodromal Parkinson’s Disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort

    S.-M. Fereshtehnejad, J. Montplaisir, A. Pelletier, J.-F. Gagnon, D. Berg, R. Postuma (Montreal, QC, Canada)

    Objective: 1) To calculate diagnostic accuracy of the Movement Disorder Society (MDS) prodromal criteria to predict conversion to Parkinson’s disease (PD) or dementia with Lewy…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley